key: cord-0926758-ab39nz3a
authors: Britton, Paul; Page, Kevin W.
title: Sequence of the S gene from a virulent British field isolate of transmissible gastroenteritis virus
date: 1990-12-31
journal: Virus Research
DOI: 10.1016/0168-1702(90)90090-x
sha: 373b1ea49a4e4d46b8b4b0be18e6cbf1430c523d
doc_id: 926758
cord_uid: ab39nz3a

Abstract Subgenomic mRNA from a virulent field isolate of porcine transmissible gastroenteritis virus (TGEV), strain FS772/70, was used to produce cDNA. The cDNA from three overlapping clones was sequenced by the chain termination method and two open reading frames (ORFs) were identified. The largest ORF, 4350bp, encoded a polypeptide of 1449 amino acids of relative molecular mass (Mr) 159811, which contained 33 potential N-linked glycosylation sites, a cysteine-rich region, and a potential transmembrane region. The C-terminal half of this ORF showed homology to the S proteins of four other coronaviruses. The other ORF consisted of the 3'-end of a gene with homology to the carboxyl terminus of the F2 subunit of infectious bronchitis virus (IBV) RNA polymerase.

Subgenomic mRNA from a virulent field isolate of porcine transmissible gastroenteritis virus (TGEV), strain FS772/70, was used to produce cDNA. The cDNA from three overlapping clones was sequenced by the chain termination method and two open reading frames (ORFs) were identified. The largest ORF, 4350bp, encoded a polypeptide of 1449 amino acids of relative molecular mass (M,) 159811, which contained 33 potential N-linked glycosylation sites, a cysteine-rich region, and a potential transmembrane region. The C-terminal half of this ORF showed homology to the S proteins of four other coronaviruses. The other ORF consisted of the 3'-end of a gene with homology to the carboxyl terminus of the F2 subunit of infectious bronchitis virus (IBV) RNA polymerase.

Transmissible gastroenteritis virus; Coronavirus; Spike; Porcine; cDNA TGEV causes gastroenteritis in pigs resulting in a high mortality and morbidity in neonates and belongs to the family Coronaviridae, a group of enveloped viruses with a positive-stranded RNA genome. Coronavirus virions contain two membrane glycoproteins spike (S), membrane (M) and a basic phospho~lated nucleoprotein (N). The TGEV S protein has a monomeric M, of 200,000 and has been shown to elicit the production of neutralising antibodies (Jimenez et al., 1986; Laude et al., 1986; Garwes et al., 1987) which are able to confer some protection on suckling piglets (Garwes et al., 1978/79) . Coronavirus S proteins either exist as a single polypeptide, TGEV, feline infectious peritonitis virus (FIPV), canine coronavirus (CCV) and porcine respiratory coronavirus (PRCV) or as two subunits, IBV, mouse hepatitis virus (MHV), bovine coronavirus (BCV) and haemagglutinating encephalomyelitis virus (HEV). Cavanagh (1983) showed that IBV S2 anchors the protein to the viral envelope via a short carboxyl-terminal hydrophobic domain and that Sl is non-covalently attached to S2. Removal of the Sl subunit abolished infectivity but not attachment to cells (Cavanagh and Davis, 1986) . In this paper, the nucleotide sequence of cloned cDNA corresponding to the S protein gene, from a virulent British field isolate of TGEV (strain FS772/70), was determined and the deduced amino acid sequence of the S protein was compared to the avirulent Purdue strain of TGEV.

TGEV poly(A)+ mRNA species were isolated from virus infected LLC-PKl cells (Britton et al., 1987) and used for the synthesis of cDNA (Britton et al., 198817) . Transformants containing TGEV cDNA were identified by colony hybridisation, using two 32P-labelled TGEV cDNA fragments Hll (derived from the S gene) and H26 (derived from the ORF-3b gene, formerly ORF 2) as described by B&ton et al. (1989) . Plasmid pTG30 contained cDNA (3.4 kbp) which hybridised to both cDNA fragments and plasmid pTG25 contained cDNA (3.2 kbp) which hybridised to Hll. Plasmid pTG30 overlapped pTG11 (Britton et al., 1989) and pTG25 in turn overlapped pTG30. A third plasmid, pTG47, contained cDNA (2.5 kbp) that overlapped pTG25 by 250 bp, but did not hybridise to Hll or H26. The cDNA from plasmids pTG30, pTG25 and pTG47 extended 10.5 kb into the viral genome, from the 3'"end, indicating that the S gene should be contained within the three plasmids.

The nucleotide sequence of the cDNA in plasmids pTG30, pTG25 and pTG47 was determined in both directions by the di-deoxy method using ~(Y-~~S]~ATP and Sequenase TM (United States Biochemical Co~oration)~ Analysis of sequence data corresponding to 6120 bp ( Fig. 1 ) revealed one complete ORF of 4350 bp, nucleotides 1600-5949, and an incomplete ORF of 1602 bp, nucleotides 2-1603, which terminated at a TGA stop codon and overlapped the 4350 bp ORF by four nucleotides. The 1602 bp incomplete ORF encoded a contiguous polypeptide of 533 amino acids potentially forming the 3'-end of a larger gene. Comparison of the 533 amino acid sequence, using a dot-matrix analysis program (DIAGON; Staden, 1982) , with the last 752 amino acids at the carboxyl terminus of the F2 subunit of the IBV polymerase (Boursnell et al., 1987) revealed very good homology (Fig. 2) , suggesting that this sequence was the 3'-end of the TGEV polymerase gene.

The 4350 bp ORF (Fig. l) , initiating from the ATG at position 1600, encoded a polypeptide of 1449 amino acids with a M, 159,811 and was preceded, 26 bp 5' to the ATG, by the potential TGEV RNA polymerase-leader complex binding site ACTAAAC. The 5'-end of this ORF mapped 8180 nucleotides from the start of the poly (A) tail indicating that it corresponded to the S gene present on the 5' coding region of mRNA 2. Comparison of the S genes from FS772/70 and two indepen- asparagine and aspartic acid giving an extra potent&& N-linked glycosylation site. This insertion has also been identified, at the same position, within the S gene sequence of the virulent Miller strain of TGEV (Wesley, 1990) . Comparison of the deduced amino acid sequences from the avirulent Purdue strain and the virulent FS772,/70 strain revealed 35 amino acid substitutions, though not all were the same for both Purdue sequences (Fig. 1) . Conservative amino acid substitutions accounted for 23 of the 35 substitutions. It is interesting to note that out of the 44 amino acid substitutions between all four TGEV sequences 19 involved amino acids that were identical for the two virulent strains of TGEV but different from those found in the two independent Purdue sequences. Analysis of the FS772/70 S protein amino acid sequence identified a 16 amino acid N-terminal membrane signal sequence with the cleavage site between the glycine (16) and aspartic acid (17) residues (score = 7.98; von Heijne, 1986) and a C-terminal hydrophobic region corresponding to the transmembrane anchor region. There are 33 potential N-linked glycosylation sites (Asn-X-Thr or Asn-X-Ser), of which 27 (82%) are Asn-X-Thr, mainly distributed over the N-terminal half of the molecule but with a group of 7 potential sites between amino acid residues 1293-1374 (Fig. 1) . Dotmatrix analysis showed that the polypeptide had homology, at the carboxyl half of the molecule, to the S proteins from the coronaviruses IBV Beaudette (Binns et al., 1985) (Boursnell et al., 1987) , by dot-matrix analysis [DIAGON; (Staden, 1982) ). The comparison used a span of II residues and a score of 136.

anchoring the TGEV S protein. The sequence, KWPWYVWL (residues 1388-1395; Fig. l) , flanking the membrane anchor region was conserved in TGEV, IBV, MHV, BCV, FIPV and HCV (except for one amino acid) indicating that it may be the site of entry into the virion membrane. One of the S protein subunits from both MHV and BCV has been shown to be acylated with pahnitic acid (Schmidt, 1982) . A cysteine rich region, residues 1404-1449 (11 cysteine residues out of the 46 amino acids), a distinctive feature of all coronavirus S proteins sequenced to date, follows the predicted transmembrane a-helix and may serve as a site for acylation with palmitic acid.

The amino acid substitutions identified between virulent and avirulent sequences may lead to the identification of differences between antigenic determinants. A region on the avirulent Purdue-115 S sequence, SSFFSYGEI (site C), has been identified as a linear monoclonal antibody (mAb) binding site (Delmas et al., 1990) , with residues FSY critical for the binding of two neutralising mAbs. Posthumus et al. (1990) showed that amino acid substitutions in the sequence, FFSYGEI, confirmed this as the primary determinant for neutralising mAbs and showed that the two Phe and the Ser, Gly and Glu residues were critical for the binding of both neutralising and non-neutralising mAbs. Delmas et al. (1990) have shown that mAbs which react with the Purdue site C do not react with the S protein from FS772/70. Comparison of this epitope on the FS772/70 sequence identified that the second Phe residue on the Purdue sequence was replaced by a Ser residue on the FS772/70 sequence, according to the data of Posthumus et al. (1990) this would prevent the binding of the Purdue derived mAbs to this epitope in TGEV FS772/70. The virulent Miller strain of TGEV also has the Phe + Ser substitution preventing Purdue-derived mAbs to this epitope from binding. The two amino acid insertion found on FS772/70 and Miller sequences was only four amino acids upstream from this epitope and may either induce a conformational change in this region of the S protein or present an extra potential N-linked glycan, both of which could also interfere with antibody binding. If the Phe -+ Ser substitution and the two amino acid insertion are features of all virulent TGEV strains it is highly unlikely that this linear epitope will be of any value in vaccine regimes, incorporating avirulent strains, for protection against virulent TGEV infections. It is also significant that polyclonal sera from pigs inoculated with the Purdue strain of TGEV did not recognise this epitope (Posthumus et al., 1990 ). S proteins from coronaviruses antigeni~ally distinct from TGEV such as MHV, IBV, BCV and HEV are post-translationally cleaved. The S protein from TGEV and from coronaviruses antigenically related such as FIPV, CCV and the recently isolated PRCV are not cleaved. The sequence DMTRG is found at residue 784 on the FS772/70 sequence and is similar to the sequences DRTRG and ERTRG, found on the Purdue (Rasschaert and Laude, 1987 ) and FIPV 79-1146 (De Groot et al., 1987 S sequences and were postulated to be reminiscent of the S protein cleavage sites. Division of the TGEV S protein, at the DMTRG site, showed there were 20 potential N-glycosylation sites and 23 amino acid substitutions, of which 16 are conservative, within the amino terminal half when comparing the virulent and avirulent strains of TGEV. Comparison of the S proteins from TGEV, FIPV, MHV, BCV and IBV revealed sequences with high homology (Fig. 1) (Britton et al., 1988a), M (Britton et al., 198813) and the genome between the S and M genes (Britton et al., 1989) , provides a complete set of sequence data, from the poly (A)-tail to the 3'-end of the polymerase gene, for a virulent field isolate of TGEV. The order of the viral genes from the FS772/70 strain of TGEV is 5'-[Pol-S-3a-3b-4-M-N-7]-3', where ORFs 3a, 3b and 4 (formerly ORFs 1, 2 and 3; Britton et al., 1989) are potential genes whose products have yet to be confirmed. ORF-7 (formerly ORF 4; Britton et al., 1988a) ,, whose product has been detected in virus infected cells (Garwes et al., 1989) has high homology to a penultimate ORF in FIPV (De Groat et al., 1988) . The identification of an incomplete ORF, 5' to the TGEV S gene, showing homology to the F2 subunit of the IBV polymerase, indicated that there are no extra gene sequences in this region of the TGEV genome, in contrast to other Martian coronaviruses BCV and MHV where other genes or pseudogenes are present, possibly resulting from recombination events.

Cloning and sequencing of the gene encoding the spike protein of the coronavirus IBV

We would like to thank Miss K. Mawditt for synthesising the oligonucleotides used in sequencing the TGEV cDNA, Dr R. Wesley for providing the sequence of the S gene from the Miller strain of TGEV prior to publication and Dr D. Pocock for helpful comments on the manuscript. This research was supported by the Biomolecular Engineering Programme of the Commission of the European Communities Contract No. ~BAP-0235-UK(H1)~.